MAPK3 and neoplasm: VIP/VIPR1 signaling maintained tumor proliferation and invasiveness by upregulating the expression of cyclins and angiogenic factors, including cyclin D1, MMP-2/MMP-9, VEGF, and COX-2, as well as stimulating tumor growth through the activation of PKA/ERK1/2 pathway 34.